Amylyx Pharmaceuticals, Inc. (AMLX)

14.11 -1.19 (-7.78%) USD  |  NASDAQ  |  Mar 03, 16:00
14.26 +0.15 (+1.06%) After-Hours: 20:00
More

Amylyx Pharmaceuticals Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for AMLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Rapt Therapeutics, Inc. Upgrade
Disc Medicine, Inc. Upgrade
Cytokinetics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
MediciNova, Inc. Upgrade